$90.61
0[0.00%]
At close: Apr 22
$90.61
0[0.00%]
PreMarket: 4:00PM EDT
Blueprint Medicines
(NASDAQ:BPMC)Blueprint Medicines Stock (NASDAQ:BPMC), Quotes and News Summary
Blueprint Medicines Stock (NASDAQ: BPMC) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 778.374K |
| Day Range | - - - |
| 52 Wk Range | 43.890 - 101.000 |
| Market Cap | $5.548B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 52 |
| Short Interest | 9.6% |
| Days to Cover | 5.06 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Blueprint Medicines Corp
Sector
Health Care
Industry
Biotechnology
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of pat...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Blueprint Medicines (BPMC) stock?
You can purchase shares of Blueprint Medicines (NASDAQ: BPMC) through any online brokerage.
Who are Blueprint Medicines's (BPMC) competitors?
Other companies in Blueprint Medicines’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
What is the target price for Blueprint Medicines (BPMC) stock?
The latest price target for Blueprint Medicines (NASDAQ: BPMC) was reported by JMP Securities on Wednesday, April 10, 2024. The analyst firm set a price target for 114.00 expecting BPMC to rise to within 12 months (a possible 25.81% upside). 36 analyst firms have reported ratings in the last year.
Current Stock Price for Blueprint Medicines (BPMC)?
The stock price for Blueprint Medicines (NASDAQ: BPMC) is $90.61 last updated April 22, 2024 at 4:00 PM EDT.
Does Blueprint Medicines (BPMC) pay a dividend?
There are no upcoming dividends for Blueprint Medicines.
When is Blueprint Medicines (NASDAQ:BPMC) reporting earnings?
Blueprint Medicines’s Q1 earnings are confirmed for Thursday, May 2, 2024.
Is Blueprint Medicines (BPMC) going to split?
There is no upcoming split for Blueprint Medicines.
What sector and industry does Blueprint Medicines (BPMC) operate in?
Blueprint Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.